Literature DB >> 2957718

Effects of extinction, pimozide, SCH 23390, and metoclopramide on food-rewarded operant responding of rats.

R J Beninger, M Cheng, B L Hahn, D C Hoffman, E J Mazurski, M A Morency, P Ramm, R J Stewart.   

Abstract

The similarity in the pattern of responding produced by extinction and dopamine (DA) receptor blockers has led to the suggestion that DA neurons may participate in the usual effects of reward on behaviour. The purpose of the present study was to evaluate the effect of receptor-subtype specific DA antagonists on food-rewarded operant responding. Rats were trained to lever press for food on a variable interval 30-s schedule. They then received one of the following treatments prior to testing on the next 5 days: saline, nonreinforcement, the DA receptor blocker pimozide (0.5 or 1.0 mg/kg), the D1 receptor blocker SCH 23390 (0.01, 0.05, 0.1 mg/kg), and the D2 receptor blocker metoclopramide (1.0, 5.0, 10.0 mg/kg). Nonreinforcement resulted in both intra- and intersession declines in responding. The drugs produced dose-dependent decreases in overall responding. Additionally, both doses of pimozide and the higher doses of SCH 23390 and metoclopramide altered intrasession patterns of responding when compared to saline, with their greatest effect being in the latter portion of the session. Intersession declines were seen with the highest doses of SCH 23390 and metoclopramide and control studies showed that these declines could not be attributed to a buildup of the drug with repeated dosing. It was concluded that both D1 and D2 receptors participate in the control of behaviour by reward.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2957718     DOI: 10.1007/bf00210842

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  25 in total

Review 1.  Multiple receptors for dopamine.

Authors:  J W Kebabian; D B Calne
Journal:  Nature       Date:  1979-01-11       Impact factor: 49.962

2.  Reduction of the rewarding effect of brain stimulation by a blockade of dopamine D1 receptor with SCH 23390.

Authors:  S Nakajima; G M McKenzie
Journal:  Pharmacol Biochem Behav       Date:  1986-04       Impact factor: 3.533

3.  Substituted benzamides as cerebral dopamine antagonists in rodents.

Authors:  P N Elliott; P Jenner; G Huizing; C D Marsden; R Miller
Journal:  Neuropharmacology       Date:  1977-05       Impact factor: 5.250

4.  A behavioural and biochemical comparison of dopamine receptor blockade produced by haloperidol with that produced by substituted benzamide drugs.

Authors:  P Jenner; A Clow; C Reavill; A Theodorou; C D Marsden
Journal:  Life Sci       Date:  1978-08-14       Impact factor: 5.037

5.  Automating the measurement of locomotor activity.

Authors:  R J Beninger; T A Cooper; E J Mazurski
Journal:  Neurobehav Toxicol Teratol       Date:  1985 Jan-Feb

6.  Decreased resistance to extinction after haloperidol: implications for the role of dopamine in reinforcement.

Authors:  A G Phillips; H C Fibiger
Journal:  Pharmacol Biochem Behav       Date:  1979-05       Impact factor: 3.533

7.  Preferential inhibition of ligand binding to calf striatal dopamine D1 receptors by SCH 23390.

Authors:  A J Cross; R D Mashal; J A Johnson; F Owen
Journal:  Neuropharmacology       Date:  1983-11       Impact factor: 5.250

8.  Affinity for the dopamine D2 receptor predicts neuroleptic potency in blocking the reinforcing effect of MFB stimulation.

Authors:  C R Gallistel; A J Davis
Journal:  Pharmacol Biochem Behav       Date:  1983-11       Impact factor: 3.533

9.  A comparison of the effects of pimozide and nonreinforcement on discriminated operant responding in rats.

Authors:  R J Beninger
Journal:  Pharmacol Biochem Behav       Date:  1982-04       Impact factor: 3.533

10.  Neuroleptic-induced "anhedonia" in rats: pimozide blocks reward quality of food.

Authors:  R A Wise; J Spindler; H deWit; G J Gerberg
Journal:  Science       Date:  1978-07-21       Impact factor: 47.728

View more
  29 in total

1.  Behavioural tests of the dopamine depletion hypothesis of neuroleptic-induced response decrement.

Authors:  P Willner; G Phillips; R Muscat; P Hood
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

2.  A matching law analysis of the effects of dopamine receptor antagonists.

Authors:  P Willner; D Sampson; G Phillips; R Muscat
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

Review 3.  The behavioral pharmacology of effort-related choice behavior: dopamine, adenosine and beyond.

Authors:  John D Salamone; Merce Correa; Eric J Nunes; Patrick A Randall; Marta Pardo
Journal:  J Exp Anal Behav       Date:  2012-01       Impact factor: 2.468

4.  The effects of haloperidol on the partial reinforcement extinction effect (PREE): implications for neuroleptic drug action on reinforcement and nonreinforcement.

Authors:  J Feldon; Y Katz; I Weiner
Journal:  Psychopharmacology (Berl)       Date:  1988       Impact factor: 4.530

5.  SCH 23390 blocks drug-conditioned place-preference and place-aversion: anhedonia (lack of reward) or apathy (lack of motivation) after dopamine-receptor blockade?

Authors:  E Acquas; E Carboni; P Leone; G Di Chiara
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

6.  Appetitive instrumental learning requires coincident activation of NMDA and dopamine D1 receptors within the medial prefrontal cortex.

Authors:  Anne E Baldwin; Kenneth Sadeghian; Ann E Kelley
Journal:  J Neurosci       Date:  2002-02-01       Impact factor: 6.167

7.  The dopamine D2 antagonist eticlopride accelerates extinction and delays reacquisition of food self-administration in rats.

Authors:  Jonathon Koerber; David Goodman; Jesse L Barnes; Jeffrey W Grimm
Journal:  Behav Pharmacol       Date:  2013-12       Impact factor: 2.293

8.  Effects of dopamine receptor antagonists on sucrose consumption and preference.

Authors:  R Muscat; P Willner
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

9.  Alpha-melanocyte stimulating hormone increases the activity of melanocortin-3 receptor-expressing neurons in the ventral tegmental area.

Authors:  Katherine Stuhrman West; Chunxia Lu; David P Olson; Aaron G Roseberry
Journal:  J Physiol       Date:  2019-05-26       Impact factor: 5.182

10.  Pharmacological characterization of performance on a concurrent lever pressing/feeding choice procedure: effects of dopamine antagonist, cholinomimetic, sedative and stimulant drugs.

Authors:  M S Cousins; W Wei; J D Salamone
Journal:  Psychopharmacology (Berl)       Date:  1994-12       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.